{
    "code": "10000497",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=10000497",
    "time": "2023-06-08 20:59:22",
    "許可證字號": "衛署菌疫輸字第000497號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "117\/05\/20",
    "發證\/登錄日期": "87\/11\/30",
    "許可證\/登錄種類": "菌　疫",
    "舊證字號": "10000497",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA01000049704",
    "中文品名": "〝基立福〞乾燥第九凝血因子注射劑",
    "英文品名": "ALPHANINE SD COAGULATION FACTOR IX(HUMAN)",
    "適應症": "預防及治療乙型血友病及缺乏第九凝血因子。",
    "劑型": "243凍晶注射劑",
    "包裝": "配製藥液轉移器: 20\/20 Mix2Vial，口徑尺寸(20 mm X 20 mm)盒裝附注入器 500 IU\/Vial小瓶 注射用水鋁蓋: Flip-off model護蓋",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "血液衍生產品",
    "監視期限": "",
    "主成分略述": "FACTOR IX",
    "限制項目": "02輸　入",
    "申請商名稱": "台灣綠十字股份有限公司",
    "申請商地址": "台北市大同區承德路三段二四四號六樓",
    "主製造廠": [
        {
            "製造廠名稱": "Grifols Biologicals LLC",
            "製造廠廠址": "5555 VALLEY BOULEVARD, LOS ANGELES, CALIFORNIA 90032",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "LABORATORIOS GRIFOLS, S.A.",
            "製造廠廠址": "POLIGONO INDUSTRIAL AUTOPISTA, PASSEIG FLUVIAL, 24, 08150 PARETS DEL VALLES, BARCELONA, SPAIN",
            "製造廠公司地址": "",
            "製造廠國別": "SPAIN",
            "製程": "注射用水製造"
        },
        {
            "製造廠名稱": "GRIFOLS BIOLOGICALS LLC",
            "製造廠廠址": "13111 TEMPLE AVENUE, CITY OF INDUSTRY, CA 91746, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": "Packaging and Labeling"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "2012100700",
            "成分名稱": "FACTOR IX",
            "含量描述": "400-625",
            "含量": "0.0000000000",
            "單位": "IU (I"
        }
    ],
    "仿單外盒": [
        {
            "title": "AlphaNine Leaflet-107-10-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000497&Seq=011&Type=9"
        },
        {
            "title": "AlphaNine Vial Label-107-10-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000497&Seq=010&Type=9"
        },
        {
            "title": "AlphaNine Diluent Label-107-10-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000497&Seq=009&Type=9"
        },
        {
            "title": "AlphaNine Box-107-10-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000497&Seq=008&Type=9"
        },
        {
            "title": "AlphaNine Vial Label-107-10-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000497&Seq=006&Type=8"
        },
        {
            "title": "AlphaNine Diluent Label-107-10-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000497&Seq=005&Type=8"
        },
        {
            "title": "AlphaNine Box-107-10-29.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=10000497&Seq=004&Type=8"
        }
    ]
}